Top Markets
Coin of the day
MGC Pharmaceuticals Limited MGC Pharmaceuticals Limited

MGC Pharmaceuticals Limited

MXC
Classement en actions #39836
MGC Pharmaceuticals Limited, an Australian biopharmaceutical firm established... MGC Pharmaceuticals Limited, an Australian biopharmaceutical firm established in West Perth in 2014, focuses on the worldwide development and distribution of plant-derived medicines. Its product portfolio encompasses both medicinal cannabis solutions and other botanical therapeutics. The company's key investigational treatments include CimetrA, currently in Phase III clinical trials for the symptomatic relief of early-stage COVID-19; CannEpil, a cannabis-based therapy undergoing Phase IIb studies for drug-resistant epilepsy; and CogniCann, which is in Phase II clinical development for alleviating dementia symptoms. Beyond these core candidates, MGC Pharmaceuticals also supplies the ArtemiC range, various other cannabinoid-infused products, and non-pharmaceutical items. Additionally, the company provides expert consulting services, particularly in clinical research. The company was previously named Erin Resources Limited before adopting its current identity, MGC Pharmaceuticals Limited, in December 2015.
Prix de l'action
$0.27239819
Dernière synchronisation: 2024-04-29
Capitalisation boursière
$330.42K
Changement (1 jour)
0.52%
Changement (1 an)
0.00%
Pays
AU
Échange MGC Pharmaceuticals Limited (MXC)

Catégorie

Historique du prix de l'action pour MGC Pharmaceuticals Limited (MXC)
Prix de clôture le plus élevé : $0.28 le 2024-04-01

Prix de clôture le plus bas : $2.78K le 2006-12-01
Historique du prix de l'action de MGC Pharmaceuticals Limited de 2006 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 -20.50%
2023 -95.74%
2022 -70.28%
2021 35.68%
2020 -7.75%
2019 -21.06%
2018 -56.01%
2017 99.41%
2016 67.92%
2015 355.81%
2014 -42.45%
2013 -89.52%
2012 -24.78%
2011 -23.17%
2010 -58.79%
2009 -24.92%
2008 -74.35%
2007 -46.31%
2006 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$165.47 28.01%
DE
$36.75 24.42%
JP
$232.21 43.16%
CH
$21.19 13.21%
IN